Search clinical trials for: ramipril

Total 176 results

Boehringer Ingelheim

Completed

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Cardiovascular Diseases

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand and more
St. Bartholomew's Hospital

Unknown

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Lymphoma | Leukemia | Anemia | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm

United Kingdom
Brigham and Women's Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)

Systemic Lupus Erythematosus | Lupus

United States
University of Michigan
Novartis Pharmaceuticals

Withdrawn

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome (SAAVE)

Hypertension | Metabolic Syndrome

United States
Boehringer Ingelheim

Completed

Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

Hypertension | Diabetes Mellitus, Type 2

Germany, France, Spain
Boehringer Ingelheim

Completed

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM (PRISMA)

Hypertension

United Kingdom, Switzerland, Austria, France, Germany, Netherlands, South Africa, Spain
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis

End Stage Renal Failure on Dialysis | Complication of Hemodialysis

United States
Ferrer Internacional S.A.

Terminated

Pharmacodynamic Clinical Trial of Cardiovascular Polypill on LDL Cholesterol

Elevated LDL Cholesterol

Spain
The University Clinic of Pulmonary and Allergic...

Unknown

Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure

Chronic Heart Failure | Cachexia

Slovenia
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)

Atrial Fibrillation

United States
Sanofi

Completed

Ramipril - Hypertension

Hypertension
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
University of Alabama at Birmingham
National Heart, Lung, and Blood Institute (NHLBI); AstraZeneca

Completed

Impact of Diabetes on Left Ventricular Remodeling (P3)

Diabetes

United States
AHEPA University Hospital
Aristotle University Of Thessaloniki

Unknown

Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy

Diabetic Nephropathy | Diabetes Type 2 | Vascular Disease

Greece
Takeda

Completed

Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension

Hypertension

Poland, Germany, Bulgaria, Russian Federation, Serbia, Sweden, Netherlands, Estonia, Slovakia, Finland
Gulhane School of Medicine

Completed

FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric Patients

Diabetic Nephropathy | Proteinuria | Chronic Kidney Disease

Turkey
Vanderbilt University

Completed

The RAS, Fibrinolysis and Cardiopulmonary Bypass

Coronary Artery Disease | Inflammation | Cardiopulmonary Bypass | Fibrinolysis | Angiotensin Receptor Blockers | Angiotensin Converting Enzyme

United States
Pfizer

Completed

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Hypertension | Blood Pressure, High

United States
Ferrer Internacional S.A.

Terminated

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Elevated LDL Cholesterol

United States
Novartis Pharmaceuticals

Completed

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure (ESCAPE-SHF)

Heart Failure

Russian Federation, Germany, Poland
Ferrer Internacional S.A.

Terminated

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure

Hypertension

United States
AstraZeneca

Completed

Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

Heart Failure | Ventricular Dysfunction, Left

Sweden
Pfizer

Terminated

A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents

Hypertension

United States, Argentina, Colombia, India, Chile, Poland, South Africa, Turkey, Ukraine
Pfizer
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Treatment of Pediatric Hypertension With Altace Trial

Hypertension

United States
NHS Greater Glasgow and Clyde

Completed

Curing Atrial Fibrillation in Heart Failure

Atrial Fibrillation | Chronic Heart Failure

United Kingdom
Aarhus University Hospital
University of Aarhus

Completed

Intensive Vasodilator Therapy in Patients With Essential Hypertension (Vasomore)

Essential Hypertension | High Blood Pressure

Denmark
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Novartis

Completed

Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients (ALIAS)

Essential Hypertension

France
Medical University of Vienna

Completed

Gene Expression Profiling in Skeletal Muscle of Healthy Subjects Treated With Ramipril

Healthy

Austria
Seoul National University Hospital

Completed

An Open-labeled Trial of Ramipril in Patients With Migraine

Migraine With Hypertension

Korea, Republic of
Novartis

Completed

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Hypertension

United States, Argentina, Colombia, France, Germany, India, Spain
Novartis

Terminated

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome (ALTO)

Hypertension With Metabolic Syndrome

United Kingdom
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria

Albuminuria

United States, Spain, Netherlands, Canada, Italy, Mexico, Israel, Australia, Russian Federation, United Kingdom, France, Germany, Latvia, Lithuania
Novartis

Completed

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Hypertension

China, India, Thailand
Novartis Pharmaceuticals

Completed

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Hypertension

United States
Novartis

Completed

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension (ATTAIN)

Hypertension

United States
Sanofi

Completed

FOCUS:Focus On Coronary Unstable Syndromes

Myocardial Ischemia
Sanofi

Completed

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Glomerulonephritis

Hong Kong
University of Pavia

Unknown

Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria

Hypertension | Type 2 Diabetes Mellitus | Microalbuminuria

Italy
Chinese University of Hong Kong

Completed

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Normal Blood Pressure | Biopsy-confirmed IgA Nephropathy | Proteinuria Less Than 0.5 g Per Day | Serum Creatinine Below 120 Umol/l

Hong Kong
St. John's Research Institute
Population Health Research Institute; Cadila Pharnmaceuticals

Completed

The Indian POLYCAP Study (TIPS)

Cardiovascular Diseases

India
Sanofi

Completed

China Medical University Hospital (CMUH) Triapin Listing

Hypertension

Taiwan
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Administered Orally as a Sprinkle on Applesauce

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited Under Fasting Conditions

Healthy

India
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ramipril 10 mg Capsules of Dr. Reddy's Laboratories Limited, Under Non-Fasting Conditions

Healthy

India
Takeda

Completed

Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.

Inflammation | Hypertension

Germany
University Magna Graecia

Completed

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

IGA Glomerulonephritis

Italy
Sanofi

Completed

Ramipril 10 mg/Day Prevention

Atherosclerosis

Bangladesh

Search clinical trials for: ramipril

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations